Skip to main content
Press Enter
BASF offers the world's largest portfolio of chemical raw materials for the pharmaceutical industry, ensuring the needs of our partners are always met. Every step of biopharmaceutical manufacturing requires high-quality raw materials delivered through a transparent, sustainable supply chain. BASF Biopharma Ingredients is committed to meeting your requirements for every ingredient we supply to the biologics industry. At BASF, we create excipients that are safe, effective, and convenient for your customers. Whether you’re developing orally disintegrating formulations that require taste-masking or modified release tablets, BASF has ingredients to deliver the precision you need, every time. At BASF, we offer a comprehensive range of cutting-edge solubilization polymers, and have an unparalleled understanding of the corresponding process technologies. BASF offers an unparalleled portfolio of excipients for topical formulations, enabling you with the tools to overcome formulation challenges. With products based on over 150 years of industry experience, BASF is committed to maintaining the highest level of quality across the product spectrum. BASF offers a broad portfolio of chemistries designed to simplify the product development process. Coating polymers are suitable for a variety of oral formulation challenges. As multifunctional excipients, ethoxylated solubilizers are known for their utility across a large range of dosage form classes. BASF's pharma grade lipid-based excipients are manufactured in GMP-compliant facilities with high quality and reliability in mind. BASF's portfolio of poloxamers are renown for their best-in-class quality. Consisting of a broad portfolio of polyethylene glycols (PEGs), BASF's portfolio of ethoxylated polymer-solubilizers is known for its versatility across a myriad of dosage forms. BASF offers a broad portfolio of functional excipients including our pharmaceutical grade polysorbate and sorbitan esters. Povidones, copovidones, and crospovidones are versatile materials that serve as the foundation of oral solid dosage forms. BASF's portfolio of solvents and co-solvents are suitable for a wide range of applications and processing methodologies. BASF offers a broad portfolio of brand families that are suitable for oral, topical, parenteral, and biologic applications. Coprocessed excipients are combination, all-in-one solutions. Kollicoat® coating polymers are suitable for a variety of oral formulation challenges. Kollicream® pharma grade solvents and emollients are manufactured in GMP-compliant facilities with high quality and reliability in mind. Kollidon® povidones, copovidones, and crospovidones are versatile materials that are most commonly used for solid oral dosage forms. Kolliphor® solubilizers, emulsifiers, co-emulsifiers, and surfactants enable the development of safe and effective formulations. Kollipro™ processing aids offer high-quality fit-for-purpose solutions that optimize manufacturing efficiency. Kollisolv® solubilizers and solvents are suitable for a wide range of applications and processing methodologies. Kolliwax® structuring agents, moisture barriers, and lubricants enable the formulation of various dosage forms. Novata® hard fats are structuring agents and matrix builders. Soluplus® is a novel solubilizer, crystallization inhibitor, and a matrix forming polymer. Explore this collection of resources to learn more about our innovative research and pharma solutions.
Date & Time Sep 15 - 18, 2025 8:00 AM - 5:00 PM CEST
In-Person / Virtual In-Person
Location 900 Boylston St Boston, MA 02115, USA
Booth 515

BPI Boston 2025: Lessons from raw material variability — Customized solutions for Bioprocessing

The biopharmaceutical industry has increasingly recognized the critical role of raw material consistency in ensuring robust and reproducible bioprocessing outcomes. Variability in raw materials, particularly in cell culture media and buffer components, can lead to significant disruptions, affecting both product quality and manufacturing efficiency. BASF has aligned with industry needs by developing application-specific solutions that mitigate performance fluctuations.

Green m Abs v1

BASF has leveraged our extensive chemistry and manufacturing knowledge to introduce specialized products tailored for biopharma applications. Notably, Kolliphor® P188 Bio and Kolliphor® P188 Cell Culture were designed to address variability in cell culture performance. These poloxamer-based excipients offer enhanced consistency by minimizing hydrophobic species and trace metal content, which are known contributors to variability. We have also offer Kollipro™ Urea Granules, a compendial GMP product for use in inclusion body solubilization and chromatography column cleaning. The granules allow for improved flowability, resulting in reduced agglomeration, and decreased preparation and handling time.

Attend our talk on Thursday September 18th at 10AM: "From Variability to Reliability: Customized Raw Material Solutions for Biomanufacturing Excellence"held by our expert David Rodriguez! 

Visit our poster: "Custom Poloxamers for shear stress protection, formulation and other applications: BASF GMP small scale manufacturing capabilities at Wyandotte (USA)", presented by our expert Jason S. Wood!

    More information

    Speakers

    David rodriguez

    David Rodriguez
    Technical Marketing Scientist, 
    BASF Pharma Solutions

    LinkedIn Profile
    Jason wood

    Dr. Jason S. Wood
    Technichal Service Manager, 
    BASF Pharma Solutions

    LinkedIn Profile

    Would you like to get in touch with our expert or book a meeting at BPI East 2025? Let's get in touch!

    Get in touch with us!